Editor's note

Governments and researchers across the globe are rushing to develop a treatment that provides immunity to COVID-19. But even if one emerges soon, the growing number of vaccine skeptics could jeopardize its effectiveness. That’s because a vaccine is only able to stop the spread of a disease if a large share of the population develops immunity.

Kristin Lunz Trujillo and Matt Motta research what makes some people hesitant to take vaccines. Their new study suggests Americans hoping a vaccine brings a quick end to the pandemic may be disappointed.

Also today:

Lynne Anderson

Senior Health + Medicine Editor

Top story

Dr. Anthony Fauci, head of the NIAID, said that a vaccination could be available as early as January, 2021. AP Photo/Alex Brandon/File

A majority of vaccine skeptics plan to refuse a COVID-19 vaccine, a study suggests, and that could be a big problem

Kristin Lunz Trujillo, University of Minnesota; Matt Motta, Oklahoma State University

As most of the world awaits a vaccine for COVID-19, a smaller group of people scoffs. They could spell real trouble in the effort to build widespread immunity.

Arts + Culture

Economy + Business


Science + Technology

Politics + Society

  • Leaders’ empathy matters in the midst of a pandemic

    Jonathan D. Fitzgerald, Regis College

    Leaders who exude empathy in the midst of the COVID-19 crisis are experiencing surges in popularity. President Donald Trump's apparent lack of empathy is becoming a campaign issue.

Environment + Energy

Most read on site